![Eilidh Fenner BSc, PhD](https://profiles-cardiff.imgix.net/attachments/7041?w=200&h=200&auto=format&crop=faces&fit=crop&q=90")
Dr Eilidh Fenner
(hi/ei)
BSc, PhD
Timau a rolau for Eilidh Fenner
Cydymaith Ymchwil, Is-adran Meddygaeth Seicolegol a Niwrowyddorau Clinigol
Trosolwg
Rwy'n Gydymaith Ymchwil Ôl-ddoethurol yn y grŵp ymchwil Psychosis yn y Ganolfan Geneteg a Genomeg Niwroseiciatrig. Mae fy ngwaith yn canolbwyntio'n bennaf ar amrywiad genetig prin sy'n gysylltiedig â sgitsoffrenia a chanlyniadau cysylltiedig.
Addysg Ôl-raddedig
PhD Niwrowyddoniaeth Integreiddiol, Prifysgol Caerdydd
Addysg Israddedig
BSc (Anrh) Gwyddorau Naturiol sy'n arbenigo mewn Niwrowyddoniaeth, Prifysgol Efrog
Cyhoeddiad
2026
- Segura, P. et al., 2026. F101. Can we sample psychosis spectrum cases from population-based cohorts? Genetic and neuroanatomical evidence from the UK Biobank [Abstract]. European Neuropsychopharmacology 111 (Supple) 113496. (10.1016/j.euroneuro.2026.113496)
- Yao, K. et al. 2026. 78. Joint modelling of polygenic risk and rare variants enhances liability-based disease prediction [Abstract]. European Neuropsychopharmacology 111 (Supple) 113105. (10.1016/j.euroneuro.2026.113105)
- Fenner, E. et al. 2026. Analysis of rare coding variants in schizophrenia-associated genes and generalised cognition in the UK Biobank. Molecular Psychiatry 31 , pp.5104-5113. (10.1038/s41380-026-03601-8)
- Smart, S. E. et al. 2026. Genetics to Improve Outcomes in Schizophrenia (GENios): A within-case molecular genetic study protocol. PLoS ONE 21 (2) e0340584. (10.1371/journal.pone.0340584)
- Kendall, K. M. et al. 2026. The relationship between schizophrenia polygenic scores, blood-based proteins and psychosis diagnosis in the UK Biobank. Schizophrenia 12 24. (10.1038/s41537-025-00725-8)
2025
- Richards, A. L. et al. 2025. Effects of shared and nonshared schizophrenia and bipolar disorder alleles on cognition and educational attainment in the UK Biobank. Biological Society: Global Open Science 5 (6) 100601. (10.1016/j.bpsgos.2025.100601)
- Smart, S. E. et al. 2025. The role of SLC39A8.p.( Ala391Thr ) in schizophrenia symptom severity and cognitive ability: cross‐sectional studies of schizophrenia and the general UK population. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 198 (7), pp.135-146. (10.1002/ajmg.b.33037)
2024
- Kappel, D. et al. 2024. Rare variants in pharmacogenes influence clozapine metabolism in individuals with schizophrenia. European Neuropsychopharmacology 80 , pp.47-54. (10.1016/j.euroneuro.2023.12.007)
2023
- Fenner, E. 2023. Discovery and impact of schizophrenia rare genetic variation using next generation sequencing. PhD Thesis , Cardiff University.
2022
- Wadon, M. et al. 2022. Clinical and genotypic analysis in determining dystonia non-motor phenotypic heterogeneity: a UK Biobank study. Journal of Neurology 269 , pp.6436-6451. (10.1007/s00415-022-11307-4)
Articles
- Segura, P. et al., 2026. F101. Can we sample psychosis spectrum cases from population-based cohorts? Genetic and neuroanatomical evidence from the UK Biobank [Abstract]. European Neuropsychopharmacology 111 (Supple) 113496. (10.1016/j.euroneuro.2026.113496)
- Yao, K. et al. 2026. 78. Joint modelling of polygenic risk and rare variants enhances liability-based disease prediction [Abstract]. European Neuropsychopharmacology 111 (Supple) 113105. (10.1016/j.euroneuro.2026.113105)
- Fenner, E. et al. 2026. Analysis of rare coding variants in schizophrenia-associated genes and generalised cognition in the UK Biobank. Molecular Psychiatry 31 , pp.5104-5113. (10.1038/s41380-026-03601-8)
- Smart, S. E. et al. 2026. Genetics to Improve Outcomes in Schizophrenia (GENios): A within-case molecular genetic study protocol. PLoS ONE 21 (2) e0340584. (10.1371/journal.pone.0340584)
- Kendall, K. M. et al. 2026. The relationship between schizophrenia polygenic scores, blood-based proteins and psychosis diagnosis in the UK Biobank. Schizophrenia 12 24. (10.1038/s41537-025-00725-8)
- Richards, A. L. et al. 2025. Effects of shared and nonshared schizophrenia and bipolar disorder alleles on cognition and educational attainment in the UK Biobank. Biological Society: Global Open Science 5 (6) 100601. (10.1016/j.bpsgos.2025.100601)
- Smart, S. E. et al. 2025. The role of SLC39A8.p.( Ala391Thr ) in schizophrenia symptom severity and cognitive ability: cross‐sectional studies of schizophrenia and the general UK population. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 198 (7), pp.135-146. (10.1002/ajmg.b.33037)
- Kappel, D. et al. 2024. Rare variants in pharmacogenes influence clozapine metabolism in individuals with schizophrenia. European Neuropsychopharmacology 80 , pp.47-54. (10.1016/j.euroneuro.2023.12.007)
- Wadon, M. et al. 2022. Clinical and genotypic analysis in determining dystonia non-motor phenotypic heterogeneity: a UK Biobank study. Journal of Neurology 269 , pp.6436-6451. (10.1007/s00415-022-11307-4)
Thesis
- Fenner, E. 2023. Discovery and impact of schizophrenia rare genetic variation using next generation sequencing. PhD Thesis , Cardiff University.